Maillard Reaction Crosslinked Alginate-Albumin Scaffolds for Enhanced Fenofibrate Delivery to the Retina: A Promising Strategy to Treat RPE-Related Dysfunction
There are limited treatments currently available for retinal diseases such as age-related macular degeneration (AMD). Cell-based therapy holds great promise in treating these degenerative diseases. Three-dimensional (3D) polymeric scaffolds have gained attention for tissue restoration by mimicking t...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-04-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/15/5/1330 |
_version_ | 1827740437933195264 |
---|---|
author | Maria Abedin Zadeh Raid G. Alany Leila Satarian Amin Shavandi Mohamed Abdullah Almousa Steve Brocchini Mouhamad Khoder |
author_facet | Maria Abedin Zadeh Raid G. Alany Leila Satarian Amin Shavandi Mohamed Abdullah Almousa Steve Brocchini Mouhamad Khoder |
author_sort | Maria Abedin Zadeh |
collection | DOAJ |
description | There are limited treatments currently available for retinal diseases such as age-related macular degeneration (AMD). Cell-based therapy holds great promise in treating these degenerative diseases. Three-dimensional (3D) polymeric scaffolds have gained attention for tissue restoration by mimicking the native extracellular matrix (ECM). The scaffolds can deliver therapeutic agents to the retina, potentially overcoming current treatment limitations and minimizing secondary complications. In the present study, 3D scaffolds made up of alginate and bovine serum albumin (BSA) containing fenofibrate (FNB) were prepared by freeze-drying technique. The incorporation of BSA enhanced the scaffold porosity due to its foamability, and the Maillard reaction increased crosslinking degree between ALG with BSA resulting in a robust scaffold with thicker pore walls with a compression modulus of 13.08 KPa suitable for retinal regeneration. Compared with ALG and ALG-BSA physical mixture scaffolds, ALG-BSA conjugated scaffolds had higher FNB loading capacity, slower release of FNB in the simulated vitreous humour and less swelling in water and buffers, and better cell viability and distribution when tested with ARPE-19 cells. These results suggest that ALG-BSA MR conjugate scaffolds may be a promising option for implantable scaffolds for drug delivery and retinal disease treatment. |
first_indexed | 2024-03-11T03:24:56Z |
format | Article |
id | doaj.art-f8c95bf4dee04546a87156bb517ba76e |
institution | Directory Open Access Journal |
issn | 1999-4923 |
language | English |
last_indexed | 2024-03-11T03:24:56Z |
publishDate | 2023-04-01 |
publisher | MDPI AG |
record_format | Article |
series | Pharmaceutics |
spelling | doaj.art-f8c95bf4dee04546a87156bb517ba76e2023-11-18T02:50:01ZengMDPI AGPharmaceutics1999-49232023-04-01155133010.3390/pharmaceutics15051330Maillard Reaction Crosslinked Alginate-Albumin Scaffolds for Enhanced Fenofibrate Delivery to the Retina: A Promising Strategy to Treat RPE-Related DysfunctionMaria Abedin Zadeh0Raid G. Alany1Leila Satarian2Amin Shavandi3Mohamed Abdullah Almousa4Steve Brocchini5Mouhamad Khoder6Drug Discovery, Delivery and Patient Care (DDDPC) Theme, School of Life Sciences, Pharmacy and Chemistry, Kingston University London, Kingston Upon Thames KT1 2EE, UKDrug Discovery, Delivery and Patient Care (DDDPC) Theme, School of Life Sciences, Pharmacy and Chemistry, Kingston University London, Kingston Upon Thames KT1 2EE, UKDepartment of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran 1665659911, Iran3BIO-BioMatter, École Polytechnique de Bruxelles, Université Libre de Bruxelles (ULB), Avenue F.D. Roosevelt, 50-CP 165/61, 1050 Brussels, BelgiumDuba General Hospital, Saudi Ministry of Health, Duba 49313, Saudi ArabiaUCL School of Pharmacy, University College London, London WC1N 1AX, UKDrug Discovery, Delivery and Patient Care (DDDPC) Theme, School of Life Sciences, Pharmacy and Chemistry, Kingston University London, Kingston Upon Thames KT1 2EE, UKThere are limited treatments currently available for retinal diseases such as age-related macular degeneration (AMD). Cell-based therapy holds great promise in treating these degenerative diseases. Three-dimensional (3D) polymeric scaffolds have gained attention for tissue restoration by mimicking the native extracellular matrix (ECM). The scaffolds can deliver therapeutic agents to the retina, potentially overcoming current treatment limitations and minimizing secondary complications. In the present study, 3D scaffolds made up of alginate and bovine serum albumin (BSA) containing fenofibrate (FNB) were prepared by freeze-drying technique. The incorporation of BSA enhanced the scaffold porosity due to its foamability, and the Maillard reaction increased crosslinking degree between ALG with BSA resulting in a robust scaffold with thicker pore walls with a compression modulus of 13.08 KPa suitable for retinal regeneration. Compared with ALG and ALG-BSA physical mixture scaffolds, ALG-BSA conjugated scaffolds had higher FNB loading capacity, slower release of FNB in the simulated vitreous humour and less swelling in water and buffers, and better cell viability and distribution when tested with ARPE-19 cells. These results suggest that ALG-BSA MR conjugate scaffolds may be a promising option for implantable scaffolds for drug delivery and retinal disease treatment.https://www.mdpi.com/1999-4923/15/5/1330alginateBSAMaillard reactionage-related-macular degenerationdrug releasefenofibrate |
spellingShingle | Maria Abedin Zadeh Raid G. Alany Leila Satarian Amin Shavandi Mohamed Abdullah Almousa Steve Brocchini Mouhamad Khoder Maillard Reaction Crosslinked Alginate-Albumin Scaffolds for Enhanced Fenofibrate Delivery to the Retina: A Promising Strategy to Treat RPE-Related Dysfunction Pharmaceutics alginate BSA Maillard reaction age-related-macular degeneration drug release fenofibrate |
title | Maillard Reaction Crosslinked Alginate-Albumin Scaffolds for Enhanced Fenofibrate Delivery to the Retina: A Promising Strategy to Treat RPE-Related Dysfunction |
title_full | Maillard Reaction Crosslinked Alginate-Albumin Scaffolds for Enhanced Fenofibrate Delivery to the Retina: A Promising Strategy to Treat RPE-Related Dysfunction |
title_fullStr | Maillard Reaction Crosslinked Alginate-Albumin Scaffolds for Enhanced Fenofibrate Delivery to the Retina: A Promising Strategy to Treat RPE-Related Dysfunction |
title_full_unstemmed | Maillard Reaction Crosslinked Alginate-Albumin Scaffolds for Enhanced Fenofibrate Delivery to the Retina: A Promising Strategy to Treat RPE-Related Dysfunction |
title_short | Maillard Reaction Crosslinked Alginate-Albumin Scaffolds for Enhanced Fenofibrate Delivery to the Retina: A Promising Strategy to Treat RPE-Related Dysfunction |
title_sort | maillard reaction crosslinked alginate albumin scaffolds for enhanced fenofibrate delivery to the retina a promising strategy to treat rpe related dysfunction |
topic | alginate BSA Maillard reaction age-related-macular degeneration drug release fenofibrate |
url | https://www.mdpi.com/1999-4923/15/5/1330 |
work_keys_str_mv | AT mariaabedinzadeh maillardreactioncrosslinkedalginatealbuminscaffoldsforenhancedfenofibratedeliverytotheretinaapromisingstrategytotreatrperelateddysfunction AT raidgalany maillardreactioncrosslinkedalginatealbuminscaffoldsforenhancedfenofibratedeliverytotheretinaapromisingstrategytotreatrperelateddysfunction AT leilasatarian maillardreactioncrosslinkedalginatealbuminscaffoldsforenhancedfenofibratedeliverytotheretinaapromisingstrategytotreatrperelateddysfunction AT aminshavandi maillardreactioncrosslinkedalginatealbuminscaffoldsforenhancedfenofibratedeliverytotheretinaapromisingstrategytotreatrperelateddysfunction AT mohamedabdullahalmousa maillardreactioncrosslinkedalginatealbuminscaffoldsforenhancedfenofibratedeliverytotheretinaapromisingstrategytotreatrperelateddysfunction AT stevebrocchini maillardreactioncrosslinkedalginatealbuminscaffoldsforenhancedfenofibratedeliverytotheretinaapromisingstrategytotreatrperelateddysfunction AT mouhamadkhoder maillardreactioncrosslinkedalginatealbuminscaffoldsforenhancedfenofibratedeliverytotheretinaapromisingstrategytotreatrperelateddysfunction |